Deuruxolitinib showed significant efficacy and safety in hair regrowth stimulation among adult patients with alopecia areata, ...
JAK inhibitors like baricitinib, ritlecitinib, and brepocitinib show promise in treating alopecia areata, with baricitinib approved by FDA and EMA. Baricitinib significantly reduced SALT scores at ...
Celiac disease is associated with an increased risk for developing alopecia areata, according to a letter to the editor published online Nov. 21 in the Journal of the American Academy of Dermatology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback